EU lists uncommon nerve disorder as side-attach of J&J COVID-19 vaccine

Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed Johnson&Johnson mark in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration

July 22 (Reuters) – Europe’s medicines regulator said on Thursday it had added a uncommon nerve-degenerating disorder, Guillain-Barré syndrome, as a likely uncommon side attach from Johnson & Johnson’s (JNJ.N) COVID-19 vaccine after it reviewed 108 situations reported worldwide.

“After assessing the accessible records, PRAC thought to be that a causal relationship between COVID-19 vaccine Janssen and GBS is potential,” the European Medicines Agency said, regarding its safety committee, PRAC.

Reporting by Pushkala Aripaka in Bengaluru; bettering by Uttaresh.V

Our Standards: The Thomson Reuters Belief Principles.

Related Articles

Back to top button
%d bloggers like this: